Tuberculosis against

Primary resistance of M. tuberculosis Primary resistance of M. tuberculosis to pyrazinamide is uncommon. In cases with known or suspected drug resistance, perform in vitro susceptibility tests with recent cultures of M. tuberculosis against pyrazinamide and the usual primary drugs. 

Rifamycia B is not biologically active but is spontaneously converted in aqueous solution to the active rifamycias O, S, and SV. Rifamycia SV was chosen for further studies because of its good in vivo activity, low toxicity, and solubiUty properties. Rifamycia SV is effective against a variety of infections as well as being active against tuberculosis and leprosy (168). Rifamycia P is the most active of the naturally occurring rifamycias (174). 

During the early 1900s, vaccines against major human epidemic diseases such as pertussis, diphtheria, tetanus, and tuberculosis were developed. Vaccines for many animal diseases were also available. In the early 1950s, the development of cell culture techniques byj. E. Enders at Harvard was followed by another series of major advances in vaccine development. Vaccines against poHo, mumps, measles, and mbeUa were Hcensed during the 1960s. 

Sudol uses fractions of coal tar rich in xylenols and ethylphenols. It is much more active and less corrosive than lysol, and remains more active in the presence of organic matter. The phenol coefficients of sudol against Mycobacterium tuberculosis, Staphylococcus aureus, and Pseudomonas aeruginosa are 6.3, 6, and 4, respectively. It also is slowly sporicidal (97). 

National Institute for Occupational Safety and Health. Protect Yourself against Tuberculosis A Respiratory Protection Guide for Health Care Workers. Washington, DC U.S. Department of Health and Human Services, 19.95. 

The thiophene analog of chloramphenicol (255) has been synthesized,as also have been similar structures. The antibacterial activity of all was much lower than that of the natural antibiotic. The thioamide of 2-thenoic acid has been prepared in a study of potential antitubercular compounds. It did not surpass thioisonico-tinamide in antitubercular activity. The thiosemicarbazones of thio-phenealdehydes and ketones (cf. Section VII,D) show high activity against Mycobacterium tuberculosis, but are very toxic. The thiosemi-carbazone of 4-(2-thienyl)-3-buten-2-one has been reported to be capable of completely inhibiting the in vitro growth of M. tuberculosis even in relatively low concentrations. ... 

Natural N-heterocycles as novel drugs against tuberculosis 98PAC365. 

Although a humoral immune response is the primaiy protection against most viral and some bacterial diseases, protective defense against other pathogens such as HIV, Plasmodium and Mycobacterium tuberculosis requires a cytotoxic response mediated by CD8+ T-cells (CTL response). Since the introduction of the vaccination concept by Jenner almost 200 yeats ago, only few vaccines have been developed that are able to induce a CTL response. These vaccines are usually attenuated live vaccines that are accompanied by certain risks and are not readily available for most pathogens. The immense appeal of DNA vaccines can be attributed to a considerable part to the fact that they are able to induce... 

Most aiititubercular drag s are bacteriostatic (slow or retard the growth of bacteria) against the M. tuberculosis bacillus. These dm usually act to inhibit bacterial cell wall synthesis, which slows the multiplication rate of the bacteria. Only isoniazid is bactericidal, with rifampin and streptomycin having some bactericidal activity. 

Aiititubercular drug s are used in combination with other aiititubercular dm to treat active tuberculosis. Isoniazid (INH) is the only aiititubercular drug used alone While isoniazid is used in combination with other drains for the treatment of primary tuberculosis, a primary use is in preventive therapy (prophylaxis) against tuberculosis. For example, when a diagnosis of tuberculosis is present, family members of the infected individual must be given prophylactic treatment with isoniazid for 6 months to 1 year. Display 12-1 identifies prophylactic uses for isoniazid. 

Discovery of Kanamycin, and Establishment oflMC. Chloramphenicol, chlor- and oxy-tetracyclines, and pyridomycin (H. Umezawa, 1967) were active, in in vitro experiments, against strains of tuberculosis, but these drugs, in contrast to streptomycin, were clinically inactive. H. Umezawa... 

Stiepton dn was isolated by Waksman in 1944, and its activity against M tuberculosis ensured its use as a primaiy ding in the treatment of tuberculosis. Unfortunately, its ototoxicity and the rapid development of resistance have tended to modify its usefulness, and although it still remains a front-hne dmg against tuberculosis it is usually used in combination with isoniazid and p(4)-aminosalicyhc acid (section 11.5). Streptomycin also shows activity against other types of bacteria,... 

Kanamycin (a complex of three antibiotics. A, B and C) is active in low concentrations against various Gram-positive (including penicillin-resistant staphylococci) and Gram-negative bacteria. It is a recognized second-line dmg in the treatment of tuberculosis. 

Capreomycin and viomycin show activity against M. tuberculosis and may be regarded as being second-line antituberculosis drugs. 

Humoral antibodies of the IgG elass are able to eross the placenta flxm mother to fetus. These antibodies will provide passive proteetion of the new-born against those diseases which involve humoral immunity and to which the mother is immune. In this fashion, new-born infants in the UK have passive proteetion against tetanus but not against tuberculosis which requires cell-mediated immunity. Seeretory antibodies are also passed to the new-born together with the first deliveries of breast milk (colostrum). Such antibodies provide some passive protection against infections of the gastrointestinal tract. 

The antimicrobial activity of thiosemicarbazones against Mycobacterium tuberculosis in vitro was first reported by Domagk et al. [28] and later confirmed in vivo [29]. Screening revealed that only certain substituted be-nzaldehyde and heterocyclic thiosemicarbazones possess antitubercular activity [30-32]. The most widely used is p-acetamidobenzaldehyde thiosemicarbazone (trivial name = thiacetazone), 1. 

---